So, has anyone been following PSYCF - PSYCHED WELLNESS?

They are the Only public company developing products from the Amanita muscaria mushroom 🍄.

The potential to dominate the market is enormous !

What do you guys think about buying $10 calls for August 16 2024 on CMPS?

MAPS FDA approval date is planned for August 11 and while I was doubting if they would get accepted before, the response from therapists involved with the stage 3 trials has put me at ease. MDMA approval could significantly boost share prices across the whole sector (e.g. see what happened to weed stocks after the recent DEA announcement).

I know it remains a risk but at about $11,65 the $10 call breaks even when compared to buying shares. There is of course significant upside when it goes higher (and significant downside when it drops... :). The $10 performs better than the $12,5 until a share price of $17,38 which is why I think the $10 one is the better choice for me as it 1) limits risk when compared to the $12,5 one and 2) still has significant upside. Not thinking of dumping a huge amount (maybe 2-3k) in but would be nice to leverage part of my portfolio. I do have a financial eduction but its been a long time since I worked in the space and never bought options on the market so thats why I can use some feedback on this thought :)

Would be great if there is someone who has some advice for me.

https://www.businesswire.com/news/home/20240504827982/en/

This thread is for questions and general discussion relating to the legal psychedelics industry. For more live discussion, visit our Discord server.

Tell me it wasn’t a bad trip.Holding the bag on TRYP.Any good info about research and potential good test results.I can wait it out till for years but must be close to going tits up

This thread is for questions and general discussion relating to the legal psychedelics industry. For more live discussion, visit our Discord server.

Spravoto was FDA approved in 2019 and J&J has gone up since but not as much as I thought it would. They are settling a lawsuit could that be the reason. Should we expect similar returns when any of the psychedelic stocks get approved.

https://ca.finance.yahoo.com/news/awakn-life-sciences-discusses-filing-220000130.html

This thread is for questions and general discussion relating to the legal psychedelics industry. For more live discussion, visit our Discord server.

https://stonegateinc.com/download/gad-report/?wpdmdl=817&refresh=663240469ffce1714569286 (16 pages)

An analysis of over 40 companies dedicated to GAD treatment reveals Mindmed, Incannex, and Compass Pathways are poised to revolutionize the landscape of anxiety treatment, particularly in the realm of generalized anxiety disorder

Mindmed, Incannex, and Compass Pathways stand at the forefront of a transformative shift in anxiety treatment paradigms. MindMed suggests that absence of psychotherapy in the treatment offered by them is an advantage.

Incannex however believes in integrating psychotherapy with psilocybin for more lasting effects. Their dedication to pioneering solutions, coupled with a deep understanding of the complexities surrounding anxiety disorders, positions them as key players in the journey towards more effective, patient-centered care. By leveraging cutting-edge research, innovative therapies, and a commitment to addressing unmet medical needs, these companies are paving the way for a future where individuals living with GAD can experience improved quality of life and greater peace of mind.

I don’t just mean aesthetically although yes that too, PN is the ultimate wellness guru, basically the male Gwenyth Paltrow, I think he’s very image-conscious as evidenced by the fact that he’s frequented this sub and changed his LinkedIn accordingly, and the weird botted Instagram comments. Numinus has a beautiful website, and honestly a stunning amount of different services, from psychiatry all the way to transcranial magnetic stimulation (a type of non-invasive magnetic brain stimulation that’s still being researched but shows promise with treatment-resistant depression). They have an office in a decent building in east Vancouver, it’s all pretty impressive to me for a business/industry so new. They seem to still be scaling up when their stock is way down, im confused as someone who doesn’t know the stock market very well yet, what are people’s thoughts? I remember people in this sub saying that they’re running out of money.

Im not trying to be a hater btw, I want them to do well so I can make my money back. Is anyone buying rn? Curious

On the one hand I see multiple red flags with this company, and on the other hand I acknowledge that I dont really know what I’m talking about

​

Ponzi Scam

https://www.prnewswire.com/news-releases/gilgamesh-announces-initiation-of-phase-2a-trial-of-gm-1020-in-major-depressive-disorder-302132468.html?tc=eml_cleartime

This thread is for questions and general discussion relating to the legal psychedelics industry. For more live discussion, visit our Discord server.